Publicaciones en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (67)

2024

  1. Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 3, pp. 96-102

2023

  1. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 10, pp. 2591-2596

  2. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  2. Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review

    Life, Vol. 12, Núm. 8

2021

  1. Contrast FFR plus intracoronary injection of nitro-glycerine accurately predicts FFR for coronary stenosis functional assessment

    Minerva Cardiology and Angiology, Vol. 69, Núm. 4, pp. 449-457

  2. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  3. Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response

    AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127

  4. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 5, pp. e96-e102

  5. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 9, pp. 2375-2379

  6. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain

    Clinical Microbiology and Infection

  7. Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer

    Scientific Reports, Vol. 11, Núm. 1

  8. Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis

    Life, Vol. 11, Núm. 9

2020

  1. Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus–Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review

    Transplantation Proceedings, Vol. 52, Núm. 2, pp. 523-526

  2. Primary Angioplasty in a Catastrophic Presentation: Acute Left Main Coronary Total Occlusion - The ATOLMA Registry

    Journal of Interventional Cardiology, Vol. 2020

  3. Using machine learning methods to determine a typology of patients with HIVHCV infection to be treated with antivirals

    PLoS ONE, Vol. 15, Núm. 1

2019

  1. Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes

    Journal of Hepatology

  2. Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study

    Journal of the European Academy of Dermatology and Venereology

  3. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54

  4. Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study

    PharmacoEconomics - Open, Vol. 3, Núm. 3, pp. 333-342